HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia
Identifieur interne : 003738 ( Istex/Corpus ); précédent : 003737; suivant : 003739HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia
Auteurs : G. J. Bhat ; V. K. Diwan ; C. Chintu ; M. Kabika ; J. MasonaSource :
- Journal of Tropical Pediatrics [ 0142-6338 ] ; 1993-08.
Abstract
Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes. A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.
Url:
DOI: 10.1093/tropej/39.4.219
Links to Exploration step
ISTEX:A878AC1AE1A4180440A2F6B7630EE82A4317A9B8Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title><author><name sortKey="Bhat, G J" sort="Bhat, G J" uniqKey="Bhat G" first="G. J." last="Bhat">G. J. Bhat</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Diwan, V K" sort="Diwan, V K" uniqKey="Diwan V" first="V. K." last="Diwan">V. K. Diwan</name><affiliation><mods:affiliation>Department of International Health Care Research, Karolinska Institutet Box 60 400, S 104 01 Stockholm, Sweden</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence to: Dr V. K. Diwan</mods:affiliation></affiliation></author><author><name sortKey="Chintu, C" sort="Chintu, C" uniqKey="Chintu C" first="C." last="Chintu">C. Chintu</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Kabika, M" sort="Kabika, M" uniqKey="Kabika M" first="M." last="Kabika">M. Kabika</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Masona, J" sort="Masona, J" uniqKey="Masona J" first="J." last="Masona">J. Masona</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A878AC1AE1A4180440A2F6B7630EE82A4317A9B8</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1093/tropej/39.4.219</idno><idno type="url">https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003738</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003738</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title><author><name sortKey="Bhat, G J" sort="Bhat, G J" uniqKey="Bhat G" first="G. J." last="Bhat">G. J. Bhat</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Diwan, V K" sort="Diwan, V K" uniqKey="Diwan V" first="V. K." last="Diwan">V. K. Diwan</name><affiliation><mods:affiliation>Department of International Health Care Research, Karolinska Institutet Box 60 400, S 104 01 Stockholm, Sweden</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence to: Dr V. K. Diwan</mods:affiliation></affiliation></author><author><name sortKey="Chintu, C" sort="Chintu, C" uniqKey="Chintu C" first="C." last="Chintu">C. Chintu</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Kabika, M" sort="Kabika, M" uniqKey="Kabika M" first="M." last="Kabika">M. Kabika</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author><author><name sortKey="Masona, J" sort="Masona, J" uniqKey="Masona J" first="J." last="Masona">J. Masona</name><affiliation><mods:affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Tropical Pediatrics</title><idno type="ISSN">0142-6338</idno><idno type="eISSN">1465-3664</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1993-08">1993-08</date><biblScope unit="volume">39</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="219">219</biblScope><biblScope unit="page" to="223">223</biblScope></imprint><idno type="ISSN">0142-6338</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0142-6338</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes. A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.</div></front></TEI><istex><corpusName>oup</corpusName><author><json:item><name>G. J. Bhat</name><affiliations><json:string>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>V. K. Diwan</name><affiliations><json:string>Department of International Health Care Research, Karolinska Institutet Box 60 400, S 104 01 Stockholm, Sweden</json:string></affiliations></json:item><json:item><name>C. Chintu</name><affiliations><json:string>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>M. Kabika</name><affiliations><json:string>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</json:string></affiliations></json:item><json:item><name>J. Masona</name><affiliations><json:string>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</json:string></affiliations></json:item></author><subject><json:item><value>Original Papers</value></json:item></subject><articleId><json:string>39.4.219</json:string></articleId><language><json:string>unknown</json:string></language><originalGenre><json:string>other</json:string></originalGenre><abstract>Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes. A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.</abstract><qualityIndicators><score>6.774</score><pdfWordCount>2998</pdfWordCount><pdfCharCount>18243</pdfCharCount><pdfVersion>1.2</pdfVersion><pdfPageCount>5</pdfPageCount><pdfPageSize>510 x 700 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>148</abstractWordCount><abstractCharCount>889</abstractCharCount><keywordCount>1</keywordCount></qualityIndicators><title>HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title><genre><json:string>other</json:string></genre><host><title>Journal of Tropical Pediatrics</title><language><json:string>unknown</json:string></language><issn><json:string>0142-6338</json:string></issn><eissn><json:string>1465-3664</json:string></eissn><publisherId><json:string>tropej</json:string></publisherId><volume>39</volume><issue>4</issue><pages><first>219</first><last>223</last></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>tropical medicine</json:string><json:string>pediatrics</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>pediatrics</json:string></scienceMetrix></categories><publicationDate>1993</publicationDate><copyrightDate>1993</copyrightDate><doi><json:string>10.1093/tropej/39.4.219</json:string></doi><id>A878AC1AE1A4180440A2F6B7630EE82A4317A9B8</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">Oxford University Press</publisher><availability><licence><p>© Oxford University Press</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</p></availability><date>1993</date></publicationStmt><notesStmt><note type="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Correspondence to: Dr V. K. Diwan</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title><author xml:id="author-0000"><persName><forename type="first">G. J.</forename><surname>Bhat</surname></persName><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation></author><author xml:id="author-0001"><persName><forename type="first">V. K.</forename><surname>Diwan</surname></persName><affiliation>Department of International Health Care Research, Karolinska Institutet Box 60 400, S 104 01 Stockholm, Sweden</affiliation><affiliation>Correspondence to: Dr V. K. Diwan</affiliation></author><author xml:id="author-0002"><persName><forename type="first">C.</forename><surname>Chintu</surname></persName><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation></author><author xml:id="author-0003"><persName><forename type="first">M.</forename><surname>Kabika</surname></persName><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation></author><author xml:id="author-0004"><persName><forename type="first">J.</forename><surname>Masona</surname></persName><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation></author><idno type="istex">A878AC1AE1A4180440A2F6B7630EE82A4317A9B8</idno><idno type="ark">ark:/67375/HXZ-0LM5BZ64-Z</idno><idno type="DOI">10.1093/tropej/39.4.219</idno><idno type="article-id">39.4.219</idno></analytic><monogr><title level="j">Journal of Tropical Pediatrics</title><idno type="pISSN">0142-6338</idno><idno type="eISSN">1465-3664</idno><idno type="publisher-id">tropej</idno><idno type="PublisherID-hwp">tropej</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1993-08"></date><biblScope unit="volume">39</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="219">219</biblScope><biblScope unit="page" to="223">223</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1993</date></creation><abstract><p>Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes. A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head></head><item><term>Original Papers</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1993-08">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-10-5">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">tropej</journal-id>
<journal-id journal-id-type="publisher-id">tropej</journal-id>
<journal-id journal-id-type="pmc">tropej</journal-id>
<journal-title>Journal of Tropical Pediatrics</journal-title>
<issn pub-type="epub">1465-3664</issn>
<issn pub-type="ppub">0142-6338</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">39.4.219</article-id>
<article-id pub-id-type="doi">10.1093/tropej/39.4.219</article-id>
<article-categories>
<subj-group>
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Bhat</surname><given-names>G. J.</given-names></name><xref ref-type="aff" rid="au1"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Diwan</surname><given-names>V. K.</given-names></name><xref ref-type="aff" rid="au2"><sup>**</sup></xref><xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chintu</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="au1"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kabika</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="au1"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Masona</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="au1"><sup>*</sup></xref>
</contrib>
<aff id="au1"><sup>*</sup><institution>Department of Paediatrics and Child Health, School of Medicine</institution> <addr-line>Lusaka, Zambia</addr-line></aff>
<aff id="au2"><sup>**</sup><institution>Department of International Health Care Research, Karolinska Institutet</institution> <addr-line>Box 60 400, S 104 01 Stockholm, Sweden</addr-line></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Correspondence to: Dr V. K. Diwan</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>1993</year>
</pub-date>
<volume>39</volume>
<issue>4</issue>
<fpage>219</fpage>
<lpage>223</lpage>
<copyright-statement>© Oxford University Press</copyright-statement>
<copyright-year>1993</copyright-year>
<abstract>
<p>Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes.</p>
<p>A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.</p>
</abstract>
</article-meta>
</front>
</article>
</istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia</title></titleInfo><name type="personal"><namePart type="given">G. J.</namePart><namePart type="family">Bhat</namePart><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V. K.</namePart><namePart type="family">Diwan</namePart><affiliation>Department of International Health Care Research, Karolinska Institutet Box 60 400, S 104 01 Stockholm, Sweden</affiliation><affiliation>Correspondence to: Dr V. K. Diwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Chintu</namePart><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Kabika</namePart><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Masona</namePart><affiliation>Department of Paediatrics and Child Health, School of Medicine Lusaka, Zambia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="other" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">1993-08</dateIssued><copyrightDate encoding="w3cdtf">1993</copyrightDate></originInfo><abstract>Even before the onset of the HIV epidemic, studies reported large variations in the protective effect of BCG against TB. The current HIV/AIDS epidemic has increased tbe incidence of tuberculosis in many countries in sub-Saharan Africa. Thus, local estimates of tbe effectiveness of BCG are needed which take prevalence of HIV into account for planning strategies for vaccination and TB control programmes. A case control study was conducted in Lusaka, Zambia. The study included 116 TB cases and 154 hospital controls. Eighty-eight per cent of controls had BCG scars compared to 77 per cent of tbe cases. BCG was not associated with TB in HIV positive children (OR 1.0, 95 per cent CI 0.2, 4.6). However, there was 59 per cent protective effect (OR 0.41,95 per cent CI 0.18,0.92) in HIV negative children. The results also suggest an eight times higher risk of TB in HIV positive children.</abstract><note type="author-notes">Correspondence to: Dr V. K. Diwan</note><relatedItem type="host"><titleInfo><title>Journal of Tropical Pediatrics</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><topic>Original Papers</topic></subject><identifier type="ISSN">0142-6338</identifier><identifier type="eISSN">1465-3664</identifier><identifier type="PublisherID">tropej</identifier><identifier type="PublisherID-hwp">tropej</identifier><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>219</start><end>223</end></extent></part></relatedItem><identifier type="istex">A878AC1AE1A4180440A2F6B7630EE82A4317A9B8</identifier><identifier type="DOI">10.1093/tropej/39.4.219</identifier><identifier type="ArticleID">39.4.219</identifier><accessCondition type="use and reproduction" contentType="copyright">© Oxford University Press</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource><recordOrigin>© Oxford University Press</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/metadata/json</uri></json:item></metadata><annexes><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/A878AC1AE1A4180440A2F6B7630EE82A4317A9B8/annexes/pdf</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003738 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003738 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A878AC1AE1A4180440A2F6B7630EE82A4317A9B8
|texte= HIV, BCG and TB in Children: A Case Control Study in Lusaka, Zambia
}}
| This area was generated with Dilib version V0.6.32. |  |